Rivera S, Kim D, Garone S, Morgenstern L, Mohsenifar Z
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Chest. 2001 Jun;119(6):1944-7. doi: 10.1378/chest.119.6.1944.
With modern medical technology, it is now possible to sustain life for prolonged periods in critically ill patients, even when there is no reasonable hope of improvement or achieving the goals of therapy. Such futile and medically inappropriate interventions may violate both the ethical and medical precepts generally accepted by patients, families, and physicians. In this study, we sought to determine who was primarily responsible for such interventions, the nature of their motivation, and the role of a timely bioethical consultation. In a retrospective review, we identified 100 patients of 331 bioethical consultations who had futile or medically inappropriate therapy. The average age of patients was 73.5 +/- 32 years (mean +/- 2 SD) with 57% being male. Fifty-seven percent of the patients were admitted to the hospital with a degenerative disorder, 21% with an inflammatory disorder, and 16% with a neoplastic disorder. The family was responsible for futile treatment in 62% of cases, the physician in 37% of cases, and a conservator in one case. Unreasonable expectation for improvement was the most common underlying factor. Family dissent was involved in 7 of 62 cases motivated by family, but never when physicians were primarily responsible. Liability issues motivated physicians in 12 of 37 cases where they were responsible but in only 1 of 62 cases when the family was (chi(2) 5 degrees of freedom = 26.7, p < 0.001). When the bioethics consultation resulted in cessation of the therapy, patients died in a median of 2 days as opposed to 16 days if therapy continued (p < 0.001).
借助现代医疗技术,现在即使在重症患者没有合理的改善希望或无法实现治疗目标的情况下,也有可能长时间维持其生命。这种无效且不符合医学规范的干预措施可能会违反患者、家属和医生普遍接受的伦理和医学准则。在本研究中,我们试图确定谁对这种干预措施负主要责任、其动机的本质以及及时进行生物伦理咨询的作用。在一项回顾性研究中,我们从331例生物伦理咨询案例中识别出100例接受了无效或不符合医学规范治疗的患者。患者的平均年龄为73.5±32岁(均值±2标准差),其中57%为男性。57%的患者因退行性疾病入院,21%因炎症性疾病入院,16%因肿瘤性疾病入院。在62%的案例中,家属对无效治疗负有责任,37%的案例中医生负有责任,1例中监护人负有责任。对改善的不合理期望是最常见的潜在因素。在62例由家属推动的案例中,有7例涉及家属异议,但在医生负主要责任时从未出现这种情况。在医生负责的37例案例中,有12例是出于责任问题的考虑,但在家属负责的62例案例中只有1例(自由度为5的卡方检验=26.7,p<0.001)。当生物伦理咨询导致治疗停止时,患者的中位死亡时间为2天,而如果继续治疗则为16天(p<0.001)。